Background Childhood obesity increases the risk of non-alcoholic fatty liver disease marked
by elevated alanine aminotransferase (ALT). This study investigated the prevalence of …

Aim We investigated the prevalence of elevated liver aminotransferases (ALT) and
additional comorbidities in a large cohort of Israeli children and adolescents with overweight …

Objective: To identify factors associated with raised alanine transaminase, aspartate
transaminase, and γ-glutaryl transferase in severely obese children Patients and Methods …

Alanine aminotransferase (ALT) elevations are considered a surrogate marker of
nonalcoholic liver disease and predict later development of diabetes and metabolic …

Objective: The objective of this study is to characterize suspected nonalcoholic fatty liver
disease (NAFLD) using elevated alanine aminotransferase (ALT) in a diverse and nationally …

Background There is evidence that nonalcoholic fatty liver disease (NAFLD) increases the
risk for dysglycemia in children in cross‐sectional studies. However, the extent to which …

Introduction Data on the prevalence of pediatric fatty liver disease remain limited, partly due
to challenges in diagnosis. A novel concept of metabolic-associated fatty liver disease …

Abstract Objectives and Study The often‐recommended alanine aminotransferase (ALT)
cutoffs (girls 21 U/l, boys 25 U/l) are based on a NHANES cohort. A novel concept of …

Background An elevated alanine aminotransferase (ALT) level is a surrogate marker of non-
alcoholic fatty liver disease (NAFLD), the most common liver disorder in adolescents. The …

Background & Aims There is a worldwide epidemic of obesity among adolescents who
subsequently are at increased risk for the development of non alcoholic fatty liver disease …